Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evofem Biosciences, Inc. (EVFM : NSDQ)
 
 • Company Description   
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.

Number of Employees: 119

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.41 Daily Weekly Monthly
20 Day Moving Average: 1,573,829 shares
Shares Outstanding: 12.15 (millions)
Market Capitalization: $4.92 (millions)
Beta: 0.02
52 Week High: $21.30
52 Week Low: $0.40
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -86.33% -85.03%
12 Week -94.37% -93.68%
Year To Date -92.80% -91.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
12400 HIGH BLUFF DRIVE SUITE 600
-
SAN DIEGO,CA 92130
USA
ph: 858-550-1900
fax: 844-828-2010
araskopf@evofem.com http://www.evofem.com
 
 • General Corporate Information   
Officers
Saundra Pelletier - President; Chief Executive Officer; and Interim Ch
Justin J. File - Chief Financial Officer
Gillian Greer - Director
Kim P. Kamdar - Director
Tony O'Brien - Director

Peer Information
Evofem Biosciences, Inc. (CORR.)
Evofem Biosciences, Inc. (RSPI)
Evofem Biosciences, Inc. (CGXP)
Evofem Biosciences, Inc. (BGEN)
Evofem Biosciences, Inc. (GTBP)
Evofem Biosciences, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 30048L203
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 12.15
Most Recent Split Date: 5.00 (0.07:1)
Beta: 0.02
Market Capitalization: $4.92 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-2.51 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-9.06 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.43
EPS Growth
vs. Year Ago Period: 65.70%
vs. Previous Quarter: 41.79%
Sales Growth
vs. Year Ago Period: 284.71%
vs. Previous Quarter: 19.08%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -254.96
12/31/21 - -225.13
09/30/21 - -173.58
Current Ratio
03/31/22 - 0.14
12/31/21 - 0.22
09/30/21 - 0.58
Quick Ratio
03/31/22 - 0.10
12/31/21 - 0.16
09/30/21 - 0.47
Operating Margin
03/31/22 - -1,417.24
12/31/21 - -2,131.09
09/30/21 - -3,402.13
Net Margin
03/31/22 - -1,676.29
12/31/21 - -2,488.99
09/30/21 - -4,011.48
Pre-Tax Margin
03/31/22 - -1,676.10
12/31/21 - -2,488.78
09/30/21 - -4,011.21
Book Value
03/31/22 - -10.54
12/31/21 - -9.59
09/30/21 - -5.68
Inventory Turnover
03/31/22 - 0.55
12/31/21 - 0.44
09/30/21 - 0.27
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©